![]() |
| Xiuchun Li is the first author of the research paper. Photo Credit: UCR/Zhou lab |
A team of researchers led by University of California, Riverside biomedical scientists has identified a small, previously overlooked small RNA molecule that plays a major role in controlling the body’s cholesterol production and the development of heart disease. The molecule, named tsRNA-Glu-CTC, could be a potential new target for future therapies aimed at lowering high cholesterol.
Using PANDORA-seq, a sequencing technology developed at UC Riverside, the scientists were able to detect hidden types of small RNAs in the liver, the organ central to cholesterol metabolism. They found that tsRNA-Glu-CTC is highly abundant in the liver (more than 65% of all detectable tsRNAs or tRNA-derived small RNAs) and responds directly to changes in cholesterol levels. The study was done in mice.
The research established a direct link between tsRNA-Glu-CTC and SREBP2 (Sterol Regulatory Element-Binding Protein 2), a key protein known as the “master regulator” of cholesterol production.
.jpg)






.jpg)

.jpg)


.jpg)

.jpg)